To the best of our knowledge, characterization

of the cross-clade neutralizing antibodies in HIV-1-infected Chinese sera was rarely reported previously. Zhang and colleagues reported serological studies on a cohort of infected homosexual men in Beijing, China, and identified plasmas with cross-clade neutralization and showed that CD4bs-specific antibodies were critical components in these samples. However, 2G12- or PG9-like antibodies were not identified [34]. In this study, we screened 80 serum samples derived from HIV-1-positive individuals against a minipanel of HIV-1 pseudoviruses, including two laboratory-adapted isolates and three primary isolates, and 8 CNsera were identified. Gp120-directed click here antibodies were prevalent,

while MPER-directed beta-catenin mutation antibodies were rare, suggesting that the cross-clade neutralizing activities of the CNsera were mainly contributed by the antibodies targeting gp120. In order to characterize the nature of the neutralization and to investigate the epitope specificity of the serum antibodies, we examined antibodies specific for the MPER, the V3 loop, the CD4bs and glycan moiety on gp120. 2F5- and 4E10-like antibodies were only detected in Serum 15 but unlike 2F5 and 4E10, these serum antibodies did not have broad neutralization activities. They accounted for about 80% Dapagliflozin neutralizing activity of Serum 15 against CNE40 but failed

to neutralize JRFL, consistent with a previous study that some sera containing 4E10-like antibody failed to neutralize 4E10-sensitive isolates [25]. The observation demonstrated that broadly neutralizing 2F5- and 4E10-like antibodies rarely developed in the Chinese individuals who were infected with mostly non-B subtypes, consistent with the observations in North America and Western Europe [35] where B subtype dominates. A plausible mechanistic explanation has been proposed for its rarity [35]. V3 peptides derived from the sequences of three primary HIV-1 isolates were synthesized. JV3 derived from a clade B isolate JRFL carries a GPGR sequence at the tip of the PND, 55V3 derived from a CRF01_AE isolate CNE55 with a GPGQ sequence at the tip of the PND and 6V3 derived from a clade B’ isolate CNE6 expresses a rare GLGR at the tip of the PND. Binding data suggested that V3 peptide-reactive antibodies were widely present in these sera, but most of the V3-directed antibodies in CNsera were not the major contributor to the cross-clade neutralization activity although some of the V3 antibodies could effectively neutralize sensitive isolates such as CNE40 and HXB2.